Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management
- PMID: 31641726
- PMCID: PMC6800406
- DOI: 10.1007/s12603-019-1273-z
Physical Frailty: ICFSR International Clinical Practice Guidelines for Identification and Management
Abstract
Objective: The task force of the International Conference of Frailty and Sarcopenia Research (ICFSR) developed these clinical practice guidelines to overview the current evidence-base and to provide recommendations for the identification and management of frailty in older adults.
Methods: These recommendations were formed using the GRADE approach, which ranked the strength and certainty (quality) of the supporting evidence behind each recommendation. Where the evidence-base was limited or of low quality, Consensus Based Recommendations (CBRs) were formulated. The recommendations focus on the clinical and practical aspects of care for older people with frailty, and promote person-centred care. Recommendations for Screening and Assessment: The task force recommends that health practitioners case identify/screen all older adults for frailty using a validated instrument suitable for the specific setting or context (strong recommendation). Ideally, the screening instrument should exclude disability as part of the screening process. For individuals screened as positive for frailty, a more comprehensive clinical assessment should be performed to identify signs and underlying mechanisms of frailty (strong recommendation). Recommendations for Management: A comprehensive care plan for frailty should address polypharmacy (whether rational or nonrational), the management of sarcopenia, the treatable causes of weight loss, and the causes of exhaustion (depression, anaemia, hypotension, hypothyroidism, and B12 deficiency) (strong recommendation). All persons with frailty should receive social support as needed to address unmet needs and encourage adherence to a comprehensive care plan (strong recommendation). First-line therapy for the management of frailty should include a multi-component physical activity programme with a resistance-based training component (strong recommendation). Protein/caloric supplementation is recommended when weight loss or undernutrition are present (conditional recommendation). No recommendation was given for systematic additional therapies such as cognitive therapy, problem-solving therapy, vitamin D supplementation, and hormone-based treatment. Pharmacological treatment as presently available is not recommended therapy for the treatment of frailty.
Keywords: 80 and over; Aged; Frailty/diagnosis; Frailty/therapy; Patient Care Planning/standards; Practice guideline.
Conflict of interest statement
E. Dent, J.E. Morley, A.J. Cruz-Jentoft, L. Rodríguez-Mañas, L.P. Fried, J. Woo, I. Aprahamian, A. Sanford, J. Lundy, J. Beilby, F.C. Martin, L. Ferrucci, R.A. Merchant, H. Arai, E.O. Hoogendijk, C.W. Won, A. Abbatecola, T. Cederholm, T. Strandberg, L.M. Gutiérrez Robledo, L. Flicker, M. Aubertin-Leheudre, H.A. Bischoff-Ferrari, J.M. Guralnik, J. Muscedere, M. Pahor, A.M. Negm, D.L. Waters declare there are no conflicts. L. Woodhouse reports personal fees from American Physical Therapy Association (APTA), personal fees from Focus on Therapeutic Outcomes (FOTO) Inc., personal fees from Canadian Physiotherapy Association (CPA), personal fees from Eli Lilly, personal fees from Scholar Rock, outside the submitted work. J.M. Bauer reports personal fees from Fresenius, personal fees from Nestlé, personal fees from Novartis, personal fees from Pfizer, personal fees from Bayer, grants and personal fees from Nutricia DANONE, outside the submitted work. J Ruiz: employees Longeveron. S. Bhasin reports grants from AbbVie, grants from Alivegen, grants from MIB, other from FPT, other from AbbVie, outside the submitted work. J.Y. Reginster reports grants and personal fees from IBSA-GENEVRIER, grants and personal fees from MYLAN, grants and personal fees from RADIUS HEALTH, personal fees from PIERRE FABRE, grants from CNIEL, personal fees from DAIRY RESEARCH COUNCIL (DRC), outside the submitted work. B. Vellas reports grants from Nestle, Nutricia, Novartis outside the submitted work.
Figures
Similar articles
-
International Clinical Practice Guidelines for Sarcopenia (ICFSR): Screening, Diagnosis and Management.J Nutr Health Aging. 2018;22(10):1148-1161. doi: 10.1007/s12603-018-1139-9. J Nutr Health Aging. 2018. PMID: 30498820
-
Screening, Diagnosis and Management of Sarcopenia and Frailty in Hospitalized Older Adults: Recommendations from the Australian and New Zealand Society for Sarcopenia and Frailty Research (ANZSSFR) Expert Working Group.J Nutr Health Aging. 2022;26(6):637-651. doi: 10.1007/s12603-022-1801-0. J Nutr Health Aging. 2022. PMID: 35718874 Review.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
The Asia-Pacific Clinical Practice Guidelines for the Management of Frailty.J Am Med Dir Assoc. 2017 Jul 1;18(7):564-575. doi: 10.1016/j.jamda.2017.04.018. J Am Med Dir Assoc. 2017. PMID: 28648901
-
Frailty and sarcopenia in elderly.Wien Klin Wochenschr. 2016 Dec;128(Suppl 7):439-445. doi: 10.1007/s00508-016-1087-5. Epub 2016 Sep 26. Wien Klin Wochenschr. 2016. PMID: 27670855 Review.
Cited by
-
Gait abnormalities and longitudinal fall risk in older patients with end-stage kidney disease and sarcopenia.BMC Geriatr. 2024 Nov 13;24(1):937. doi: 10.1186/s12877-024-05506-z. BMC Geriatr. 2024. PMID: 39538169 Free PMC article.
-
Intestinal barrier damage contributes to a higher prevalence of frailty in aging people living with HIV: a retrospective case control study in a Chinese cohort.Front Immunol. 2024 Oct 25;15:1480083. doi: 10.3389/fimmu.2024.1480083. eCollection 2024. Front Immunol. 2024. PMID: 39524438 Free PMC article.
-
Integrated care for older people improved intrinsic capacity in elderly patients: a case control study.BMC Geriatr. 2024 Oct 31;24(1):898. doi: 10.1186/s12877-024-05509-w. BMC Geriatr. 2024. PMID: 39482580 Free PMC article.
-
Sarcopenia.J Diabetes. 2024 Oct;16(10):e70025. doi: 10.1111/1753-0407.70025. J Diabetes. 2024. PMID: 39470148 Free PMC article. No abstract available.
-
Using Existing Clinical Data to Measure Older Adult Inpatients' Frailty at Admission and Discharge: Hospital Patient Register Study.JMIR Aging. 2024 Oct 28;7:e54839. doi: 10.2196/54839. JMIR Aging. 2024. PMID: 39467281 Free PMC article.
References
-
- Hoogendijk EO, Muntinga ME, van Leeuwen KM, van der Horst HE, Deeg DJ, Frijters DH, et al. Self-perceived met and unmet care needs of frail older adults in primary care. Arch Gerontol Geriatr. 2014;58(1):37–42. - PubMed
-
- Chode S, Malmstrom TK, Miller DK, Morley JE. Frailty, Diabetes, and Mortality in Middle-Aged African Americans. J Nutr Health Aging. 2016;20(8):854–9. - PubMed
-
- Vermeiren S, Vella-Azzopardi R, Beckwee D, Habbig AK, Scafoglieri A, Jansen B, et al. Frailty and the Prediction of Negative Health Outcomes: A Meta-Analysis. J Am Med Dir Assoc. 2016;17(12):1163.e1–.e17. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
